Patent details

Basic Information

Publication number:

EP1748766

PCT Application Number:

PCT/US/2005/014021

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP057401481

PCT Publication Number:

WO/2005/110380

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SUSTAINED RELEASE INTRAOCULAR IMPLANTS COMPRISING A BETA ADRENERGIC RECEPTOR ANTAGONIST AND METHODS FOR TREATING OCULAR NEUROPATHIES

French Title of Invention:

IMPLANTS INTRAOCULAIRES A LIBERATION SOUTENUE CONTENANT UN ANTAGONISTE DU RECEPTEUR BETA-ADRENERGIQUE ET METHODES DE TRAITEMENT DE NEUROPATHIES OCULAIRES

German Title of Invention:

INTRAOKULARE IMPLANTATE MIT VERZÖGERTER FREISETZUNG MIT EINEM BETA-ADRENERGEN REZEPTORANTAGONISTEN UND VERFAHREN ZUR BEHANDLUNG VON AUGENNEUROPATHIEN

SPC Number:

Dates

Filing date:

21/04/2005

Grant date:

11/06/2014

EP Publication Date:

11/06/2014

PCT Publication Date:

24/11/2005

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/02/2007

EP B1 Publication Date:

11/06/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

21/04/2015

Expiration date:

21/04/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/04/2005

 

 

Name:

ALLERGAN INC.

Address:

2525 Dupont Drive, Irvine CA 92612, United States (US)

Inventor

1

Name:

NIVAGGIOLI Thierry

Address:

United States (US)

2

Name:

HUANG Glenn, T.

Address:

United States (US)

Priority

Priority Number:

836880

Priority Date:

30/04/2004

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/70;

Filing date	Document type	Number of pages